Drug Type Interferons, Biosimilar |
Synonyms RHUIFNA-2B |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2006), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neoplasms | CN | 01 Jan 2006 | |
Virus Diseases | CN | 01 Jan 2006 |
Not Applicable | Melanoma Adjuvant | - | ksxfswzkpc(trqhjancgd) = yiipvapjsj vesnlldizi (mdfbgbzowl ) | - | 20 Jun 2007 |